| Product NDC: | 0007-4407 |
| Proprietary Name: | ARGATROBAN |
| Non Proprietary Name: | argatroban |
| Active Ingredient(s): | 100 mg/mL & nbsp; argatroban |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0007-4407 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020883 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001128 |
| Package NDC: | 0007-4407-01 |
| Package Description: | 1 VIAL in 1 CARTON (0007-4407-01) > 2.5 mL in 1 VIAL |
| NDC Code | 0007-4407-01 |
| Proprietary Name | ARGATROBAN |
| Package Description | 1 VIAL in 1 CARTON (0007-4407-01) > 2.5 mL in 1 VIAL |
| Product NDC | 0007-4407 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | argatroban |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20001128 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | ARGATROBAN |
| Strength Number | 100 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |